Skip to content
value.today

Carlsmed, Inc.

🇺🇸 La Jolla, California, USABiotechnologyFounded 2018
Total raised
$107 M
3 rounds on record
Latest round
$65 M
Mar 2024
First round on record
Dec 2020
Today
Went public
See the company page

Carlsmed, Inc. is listed today as Carlsmed, Inc.: market value, financials and filings are on its company page.

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Carlsmed, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2024$65 MNo. 3$50 to $250 million

Carlsmed, Inc.: Raise no. 3, Mar 2024

Investors in this round

7 investors had bought by the notice of Feb 7, 2025: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 10 investors are named for Carlsmed, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$65 M of $65 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Durall Scott · Executive Officer
  • Leonard Greenstein · Executive Officer
  • Michael Cordonnier · Executive Officer, Director
  • Niall Casey · Executive Officer, Director
  • Shariq Hussain · Executive Officer
  • Sharon Schulzki · Executive Officer
  • Jonathan Root · Director
  • Kevin O'Boyle · Director
  • Kevin Sidow · Director
  • Philip Young · Director
  • Robert Mittendorff · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael Cordonnier, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Feb 7, 2025. Read the notice at the SEC.

equitySEC
Apr 2022$30 MNo. 2$10 to $50 million

Carlsmed, Inc.: Raise no. 2, Apr 2022

Investors in this round

21 investors had bought by the notice of Apr 27, 2022: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 10 investors are named for Carlsmed, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$30 M of $30 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alexander Arrow · Executive Officer
  • Mark Singer · Executive Officer
  • Michael Cordonnier · Executive Officer, Director
  • Niall Casey · Executive Officer, Director
  • Shariq Hussain · Executive Officer
  • Sharon Schulzki · Executive Officer
  • Jonathan Root · Director
  • Kevin Sidow · Director
  • Philip Young · Director
  • Robert Mittendorff · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael Cordonnier, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 27, 2022. Read the notice at the SEC.

equitySEC
Dec 2020$13 MNo. 1$10 to $50 million

Carlsmed, Inc.: Raise no. 1, Dec 2020

Investors in this round

50 investors had bought by the notice of Dec 17, 2020: 50 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 10 investors are named for Carlsmed, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$13 M of $13 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alexander Arrow · Executive Officer
  • Justin Esterberg · Executive Officer
  • Michael Cordonnier · Executive Officer, Director
  • Niall Casey · Executive Officer, Director
  • Shariq Hussain · Executive Officer
  • Sharon Schulzki · Executive Officer
  • Jonathon Root · Director
  • Kevin Sidow · Director
  • Philip Young · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael Cordonnier, Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 17, 2020. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Carlsmed, Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2025).

    SEC Form D · Feb 2025

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Feb 2025

That is all the official record says: Carlsmed, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of Carlsmed, Inc. are on record.

Investors#

10 named in official filings. Open an investor to see everything it has backed.

Investors in Carlsmed, Inc.
InvestorKindAmountRoundRoleSource
B Capital Global Growth III, L.P.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2025)SEC Form 3
B Capital Group Management, L.P.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2025)SEC Form 3
B Capital Healthcare I, L.P.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2025)SEC Form 3
Hornet Co-Invest Investors, Ltd.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2025)SEC Form 3
Hornet Co-Invest, LPFund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2025)SEC Form 3
Kevin SidowPersonnot statednot statedHeld Series B preferred stock, director (Form 3, 2025)SEC Form 3
Michael CordonnierPersonnot statednot statedHeld Series B preferred stock, director (Form 3, 2025)SEC Form 3
Niall CaseyPersonnot statednot statedHeld Series B preferred stock, director (Form 3, 2025)SEC Form 3
Presidio Management Group XII, L.L.C.Fund or asset managernot statednot statedHeld Series A, B and C preferred stock, 10% owner (Form 3, 2025)SEC Form 3
U.S. Venture Partners XII, L.P.Venture capitalnot statednot statedHeld Series A, B and C preferred stock, 10% owner (Form 3, 2025)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 50 investors.

Largest shareholders today

Institutions holding Carlsmed, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Carlsmed, Inc.
NameRoleNamed in
Durall ScottExecutive officerFeb 2025
Leonard GreensteinExecutive officerFeb 2025
Michael CordonnierExecutive officerFeb 2025
Niall CaseyExecutive officerFeb 2025
Shariq HussainExecutive officerFeb 2025
Sharon SchulzkiExecutive officerFeb 2025
Alexander ArrowExecutive officerApr 2022
Mark SingerExecutive officerApr 2022
Justin EsterbergExecutive officerDec 2020
Jonathan RootDirectorFeb 2025
Kevin O'BoyleDirectorFeb 2025
Kevin SidowDirectorFeb 2025
Michael CordonnierDirectorFeb 2025
Niall CaseyDirectorFeb 2025
Philip YoungDirectorFeb 2025
Robert MittendorffDirectorFeb 2025
Jonathon RootDirectorDec 2020

Went public since 2025. Its SEC number is that of a company listed on a stock exchange.